1.Phase III Randomized Trial of ACNU in Addition to Surgery and Radiotherapy for Patients with Malignant Glioma of the Brain: A Preliminary Report.
Hee Won JUNG ; Chun Kee CHUNG ; Je G CHI ; Yung Jue BANG ; Dae Seog HEO ; Yoon Ok AHN ; Il Han KIM ; Noe Kyeong KIM ; Kil Soo CHOI ; Dae Hee HAN
Journal of Korean Neurosurgical Society 1992;21(9):1095-1101
No abstract available.
Astrocytoma
;
Brain*
;
Drug Therapy
;
Glioblastoma
;
Glioma*
;
Humans
;
Nimustine*
;
Radiotherapy*
2.Effects of Bladder Training and/or Tolterodine in Female Patients with Overactive Bladder Syndrome: A Prospective, Randomized Study.
Cheryn SONG ; Jun Tag PARK ; Kyeong Ok HEO ; Kyu Sung LEE ; Myung Soo CHOO
Journal of Korean Medical Science 2006;21(6):1060-1063
We compared the effects of bladder training and/or tolterodine as first line treatment in female patients with overactive bladder (OAB). One hundred and thirty-nine female patients with OAB were randomized to treatment with bladder training (BT), tolterodine (To, 2 mg twice daily) or both (Co) for 12 weeks. Treatment efficacy was measured by micturition diary, urgency scores and patients' subjective assessment of their bladder condition. Mean frequency and nocturia significantly decreased in all treatment groups, declining 25.9% and 56.1%, respectively, in the BT group; 30.2% and 65.4%, respectively, in the To group; and 33.5% and 66.3%, respectively in the Co group (p<0.05 for each). The decrease in frequency was significantly greater in the Co group than in the BT group (p<0.05). Mean urgency score decreased by 44.8%, 62.2% and 60.2% in the BT, To, and Co groups, respectively, and the improvement was significantly greater in the To and Co groups than in the BT group (p<0.05 for each). Although BT, To and their combination were all effective in controlling OAB symptoms, combination therapy was more effective than either method alone. Tolterodine alone may be instituted as a first-line therapy, but may be more effective when combined with bladder training.
Urinary Bladder, Overactive/*therapy
;
Treatment Outcome
;
Toilet Training
;
Phenylpropanolamine/*therapeutic use
;
Outcome Assessment (Health Care)
;
Muscarinic Antagonists/therapeutic use
;
Middle Aged
;
Humans
;
Female
;
Cresols/*therapeutic use
;
Combined Modality Therapy
;
Benzhydryl Compounds/*therapeutic use
;
Behavior Therapy/*methods
3.Prescribing Patterns of Pain Medication in Hospitalized Elderly Patients with Non-Cancer Pain.
Ki Nam NAM ; Eun Ok CHOI ; Beam Hae KIM ; Sae Ra SEONG ; Yoo Jeong HEO ; Kyeong Ju LEE ; Yu Jeung LEE
Korean Journal of Clinical Pharmacy 2015;25(3):145-150
OBJECTIVE: Pain is very common in the elderly, so there is a high prevalence of analgesic use among this population. The purpose of this study was to assess patterns of analgesic use and evaluate factors associated with analgesic use in elderly patients. METHOD: The subjects of this study were patients over 65 years old hospitalized in a teaching hospital located in Chuncheon-si, Korea between January 1, 2014 and March 31, 2014. Data collection regarding analgesic prescriptions and baseline characteristics was conducted using computerized hospital database by medical information team. Logistic regression analysis was used to identify factors related to analgesic use. RESULTS: A total of 2,394 patients were finally included. Among these patients, 700 (29.2%) took analgesics; 521 (74.4%) out of these 700 patients were received opioid analgesics and 179 (25.6%) were received only non-opioid analgesics. The most frequently prescribed opioid analgesic was pethidine (45.7%), and the most frequently prescribed non-opioid analgesic was acetaminophen (44.1%). Fracture was associated with increased odds of opioid analgesic prescriptions (OR = 2.766, 95% CI = 2.019-3.790, p < 0.001) and any analgesic prescriptions (OR = 2.394, 95% CI = 1.766-3.244, p < 0.001). Stroke or cerebral infarction was associated with decreased odds of opioid analgesic prescriptions (OR = 0.636, 95% CI = 0.471-0.858, p = 0.003). CONCLUSION: A significant proportion of hospitalized elderly patients use analgesics. Health care professionals should consider factors associated with analgesic use in this population to improve pain management.
Acetaminophen
;
Aged*
;
Analgesics
;
Analgesics, Opioid
;
Cerebral Infarction
;
Data Collection
;
Delivery of Health Care
;
Gangwon-do
;
Hospitals, Teaching
;
Humans
;
Korea
;
Logistic Models
;
Meperidine
;
Pain Management
;
Prescriptions
;
Prevalence
;
Stroke
4.Phase III Randomized Trial of ACNU in Addition to Surgery and Radiotherapy for Patients with Supratentorial Malignant Gliomas.
Hee Won JUNG ; Chang Wan OH ; Chun Kee CHUNG ; Hee Jin YANG ; Kil Soo CHOI ; Dae Hee HAN ; Je G CHI ; Yung Jue BANG ; Dae Seog HEO ; Noe Kyeong KIM ; Yoon Ok AHN ; Il Han KIM
Journal of the Korean Cancer Association 1997;29(4):608-615
No abstract available
Drug Therapy
;
Glioma*
;
Humans
;
Nimustine*
;
Radiotherapy*
5.Incidence estimation of stomach cancer among Koreans.
Yoon Ok AHN ; Byung Joo PARK ; Keun Young YOO ; Noe Kyeong KIM ; Dae Soeg HEO ; Jung Kwon LEE ; Hyeong Sik AHN ; Dae Hee KANG ; Hoen KIM ; Moo Song LEE ; Tae Soo PARK
Journal of Korean Medical Science 1991;6(1):7-14
A series of incidence estimation studies of cancers among Koreans through a nationwide survey has been undertaken by authors since 1988. The medical records were studied of inpatients with diagnoses of either ICD-9 151 (malignant neoplasm of the stomach), or 197 (secondary malignant neoplasm of the respiratory and digestive systems), or 211 (benign neoplasm of other parts of the digestive system) in claims sent in by medical care institutions throughout the country to the Korea Medical Insurance Corporation (KMIC) during the period from January 1, 1986 to December 31, 1987. These records were abstracted in order to identify and confirm the new cases of stomach cancer among the beneficiaries of the KMIC, which covers about 10% of whole Korean population. Using these data from the KMIC, the incidence patterns of stomach cancer among Koreans were estimated as of July 1, 1986 to June 30, 1987. The crude incidence rates of stomach cancer among Koreans are estimated to be 36.2 (95% tonfidence interval; 35.3-36.9) and 21.0 (95% CI; 20.3-21.6) per 100,000 in males and females, respectively. The cumulative rates for age spans 0-64 and 0-74 are 3.8% and 7.3% in males, respectively. In females they are 1.8% and 3.0%. The adjusted rates for the world population are 57.9 in males and 25.1 in females, which are similar to those of Shanghai, China '78-'82 but lower than those of Osaka, Japan. The truncated rates for ages 35-64 years, however, are 108.3 in males and 49.1 in females, which may be the highest in the world. Among Koreans in Korea, an increased risk of stomach cancer in this age group is the notable finding. Incidence patterns of stomach cancer by age, sex, and area, which are the first report in Korea, are analyzed and presented.
Adolescent
;
Adult
;
Age Factors
;
Aged
;
Aged, 80 and over
;
Epidemiologic Factors
;
Female
;
Humans
;
Korea/epidemiology
;
Male
;
Middle Aged
;
Sex Factors
;
Stomach Neoplasms/*epidemiology
6.Transradial Versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using SecondGeneration Drug-Eluting Stent
Jung-Hee LEE ; Young Jin YOUN ; Ho Sung JEON ; Jun-Won LEE ; Sung Gyun AHN ; Junghan YOON ; Hyeon-Cheol GWON ; Young Bin SONG ; Ki Hong CHOI ; Hyo-Soo KIM ; Woo Jung CHUN ; Seung-Ho HUR ; Chang-Wook NAM ; Yun-Kyeong CHO ; Seung Hwan HAN ; Seung-Woon RHA ; In-Ho CHAE ; Jin-Ok JEONG ; Jung Ho HEO ; Do-Sun LIM ; Jong-Seon PARK ; Myeong-Ki HONG ; Joon-Hyung DOH ; Kwang Soo CHA ; Doo-Il KIM ; Sang Yeub LEE ; Kiyuk CHANG ; Byung-Hee HWANG ; So-Yeon CHOI ; Myung Ho JEONG ; Hyun-Jong LEE
Journal of Korean Medical Science 2024;39(10):e111-
Background:
The benefits of transradial access (TRA) over transfemoral access (TFA) for bifurcation percutaneous coronary intervention (PCI) are uncertain because of the limited availability of device selection. This study aimed to compare the procedural differences and the in-hospital and long-term outcomes of TRA and TFA for bifurcation PCI using secondgeneration drug-eluting stents (DESs).
Methods:
Based on data from the Coronary Bifurcation Stenting Registry III, a retrospective registry of 2,648 patients undergoing bifurcation PCI with second-generation DES from 21 centers in South Korea, patients were categorized into the TRA group (n = 1,507) or the TFA group (n = 1,141). After propensity score matching (PSM), procedural differences, in-hospital outcomes, and device-oriented composite outcomes (DOCOs; a composite of cardiac death, target vessel-related myocardial infarction, and target lesion revascularization) were compared between the two groups (772 matched patients each group).
Results:
Despite well-balanced baseline clinical and lesion characteristics after PSM, the use of the two-stent strategy (14.2% vs. 23.7%, P = 0.001) and the incidence of in-hospital adverse outcomes, primarily driven by access site complications (2.2% vs. 4.4%, P = 0.015), were significantly lower in the TRA group than in the TFA group. At the 5-year follow-up, the incidence of DOCOs was similar between the groups (6.3% vs. 7.1%, P = 0.639).
Conclusion
The findings suggested that TRA may be safer than TFA for bifurcation PCI using second-generation DESs. Despite differences in treatment strategy, TRA was associated with similar long-term clinical outcomes as those of TFA. Therefore, TRA might be the preferred access for bifurcation PCI using second-generation DES.